Alivus Life Sciences Limited

Alivus Life Sciences Limited - ROEverified

ALIVUS.NS

Price:

$1337.2

Market Cap:

$164.13B

Alivus Life Sciences Limited, a Mumbai, India-headquartered entity established in 2001, operates as a subsidiary of Nirma Limited. Having rebranded from Glenmark Life Sciences Limited in December 2024, the company specializes in the development, production, and global commercialization of active pharmaceutical ingredients (APIs). Its market footprint spans India, Japan, Europe, and both North and Latin America, supported by substantial export operations. Alivus Life Sciences provides an extensive catalog of APIs, including olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, r...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-08-06

Stock Exchange

NSE

Ticker

ALIVUS.NS

The ROE as of October 2026 (TTM) for Alivus Life Sciences Limited (ALIVUS.NS) is 19.00%

According to Alivus Life Sciences Limited’s latest financial reports and current stock price. The company's current ROE is 19.00%. This represents a change of 726.67% compared to the average of 2.30% of the last 4 quarters.

Alivus Life Sciences Limited (ALIVUS.NS) Historical ROE (quarterly & annually)

How has ALIVUS.NS ROE performed in the past?

The mean historical ROE of Alivus Life Sciences Limited over the last ten years is 17.09%. The current 19.00% ROE has changed 11.19% with respect to the historical average. Over the past ten years (40 quarters), ALIVUS.NS's ROE was at its highest in in the March 2025 quarter at 5.04%. The ROE was at its lowest in in the March 2024 quarter at 0%.

Quarterly (TTM)
Annual

Average

17.09%

Median

17.09%

Minimum

16.94%

Maximum

17.24%

Alivus Life Sciences Limited (ALIVUS.NS) ROE by Quarter and Year

Discovering the peaks and valleys of Alivus Life Sciences Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 17.24%

Minimum Annual Increase = -1.72%

Minimum Annual ROE = 16.94%

Quarterly (TTM)
Annual
YearROEChange
202616.94%-1.72%

Alivus Life Sciences Limited (ALIVUS.NS) Average ROE

How has ALIVUS.NS ROE performed in the past?

The current ROE of Alivus Life Sciences Limited (ALIVUS.NS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

17.09%

5-year avg

17.09%

10-year avg

17.09%

Alivus Life Sciences Limited (ALIVUS.NS) ROE vs. Peers

How is ALIVUS.NS’s ROE compared to its peers?

Alivus Life Sciences Limited’s ROE is less than Alembic Pharmaceuticals Limited (12.62%), less than Ipca Laboratories Limited (16.00%), less than NATCO Pharma Limited (12.80%), less than Cohance Lifesciences Limited (2.74%), less than Bal Pharma Limited (8.98%), less than Morepen Laboratories Limited (11.50%), less than Laurus Labs Limited (21.36%), less than Granules India Limited (14.61%), less than SMS Pharmaceuticals Limited (13.52%), less than Aarti Pharmalabs Limited (10.22%),

Build a custom stock screener for Alivus Life Sciences Limited (ALIVUS.NS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alivus Life Sciences Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alivus Life Sciences Limited (ALIVUS.NS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alivus Life Sciences Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Alivus Life Sciences Limited's ROE?

How is the ROE calculated for Alivus Life Sciences Limited (ALIVUS.NS)?

What is the highest ROE for Alivus Life Sciences Limited (ALIVUS.NS)?

What is the 3-year average ROE for Alivus Life Sciences Limited (ALIVUS.NS)?

What is the 5-year average ROE for Alivus Life Sciences Limited (ALIVUS.NS)?

How does the current ROE for Alivus Life Sciences Limited (ALIVUS.NS) compare to its historical average?